Hematology/Oncology News

Leading dermatology organizations called on the U.S. surgeon general to continue its call to action to prevent skin cancer, the American Society for Dermatologic Surgery Association announced in a press release.

SGLT2 inhibition may prevent cancer therapy-related cardiac dysfunction and improve other outcomes in patients with diabetes undergoing cancer therapy, researchers reported.

Healio spoke with Naval Daver, MD, about presentations on the use of molecular therapies, including menin inhibitors, in the treatment of acute myeloid leukemia from Society of Hematologic Oncology Annual Meeting.

Diversity and equity in health care doesn’t just benefit underrepresented populations.

Older cancer survivors exhibited increased risk for cardiovascular disease than cancer-free individuals of the same age, according to a secondary analysis of a randomized study.

CHICAGO — The presence of breast arterial calcifications on routine mammograms may signal increased risk for atherosclerotic CVD later in life, according to research presented at the Annual Meeting of The Menopause Society.

Time in the market is far more important than timing the market. Long-term investors will utilize both the strategies of dollar cost averaging and lump sum investing to reach their investment goals.

September is National Sickle Cell Awareness Month.

The FDA approved isatuximab-irfc in combination with bortezomib, lenalidomide and dexamethasone for treatment of certain adults with multiple myeloma.

The FDA has missed its action date to address its proposed rule banning formaldehyde and formaldehyde-releasing chemicals from hair smoothing and straightening products.